Swiss med device firm Debiotech and dialysis device developer Fresenius Medical said today they are partnering to develop home-usable peritoneal dialysis technologies. The companies said they aim to create a platform of dialysis machines that are lightweight and compact to allow patients to travel with the device and use them at home. The newly partnered […]
Fresenius
Fresenius Medical Care sees strong profit growth in 2016
China halts anti-dumping probe into EU, Japan dialysis kit makers
Fresenius Medical takes over U.S. healthcare group Cogent
Fresenius ends Russia joint venture, feels impact of Ukraine crisis
Conor MedSystems can’t slip $100 million breach of contract lawsuit | Medtech legal news for the week of May 26, 2014
Supreme Court declines review of Baxter/Fresenius patent row
Fresenius’ renal research division gets a makeover
Biomet puts itself back on public market | Medtech Wall Street news for the week of Mar. 10, 2014
Biomet announces IPO plans
March 7, 2014 by Brad Perriello
Biomet is planning to put itself back on the public market after a 7-year run under private equity ownership, the orthopedics giant said today.
Siemens, GE named among worst-performing device makers of the year | MassDevice.com On Call
MASSDEVICE ON CALL — Medtech giants have seen Wall Street bumps so far this year, but several of the company’s in the industry’s top 40 haven’t been so fortunate.
NxStage, Fresenius extend System One deal
Fresenius (NYSE:FMS) and NxStage Medical (NSDQ:NXTM) said they extended a supply deal for NxStage’s System One hemodialysis device until 2016.